iForumRx.org University of Mississippi School of Pharmacy

Identifying and addressing the social determinants of health (SDOH) influences health outcomes and can positively impact health equity in our society.  While health systems in the US are screening for SDOH more often, information on how to improve screening efficiency and effectiveness is lacking. A recently published study was designed to determine what patient and clinician factors are associated with early implementation of SDOH screening in primary care.
Guest Author: Sharmon P. Osae, PharmD, BCACP, CDCES
Music by: Good Talk

This episode is a collaboration between the ACCP Ambulatory Care Practice and Research Network (PRN) ... and iForumRx.org.
Mental illness is very common - 1 in 5 adults in the United States will have a mental illness during their lifetime.  Every ambulatory care (and community) pharmacist should be confident in their ability to recognize mental health challenges and how to use medications in an optimal manner to treat them.  This is a FOLLOW-UP conversation from the ACCP Annual Meeting program entitled Ambulatory Care PRN Focus Session — Breaking Down Depression and Anxiety Management for the Ambulatory Care Pharmacist.
Expert Panelists:  Richard Silvia, PharmD, BCPP and Jordan Baye, PharmD, BCPS
Music by lemonmusicstudio from Pixabay

Reason for Visit:  Referred by primary care provider to pharmacy services for education and management; diabetes not responding to oral therapy.
Guest Authors: Jillian Cerullo, PharmD and Michelle Gauvin, PharmD, BCACP, BCGP, CDCES
Expert Panelists: Jennifer Trujillo, PharmD, BCPS, CDCES, BC-ADM and Joshua Neumiller, PharmD, CDCES
Music by Good Talk

Weight extremes, a body-mass index (BMI) either very underweight or obese, are associated with increased all-cause mortality.  Mortality attributable to obesity is caused by many secondary conditions like metabolic disorders and cardiovascular (CV) disease. Enter the glucagon-like peptide-1 (GLP-1) receptor agonists—initially approved in the treatment of type 2 diabetes— which induce significant weight loss regardless of diabetes status.  But can a weight loss drug decrease CV mortality?
Guest Authors:  Gregory Castelli, PharmD, BCPS, BC-ADM, CDCES and Drake Meaney, PharmD, BCPS
Music by Good Talk

Pharmacists are the most accessible health professionals and can play a vital role in screening and managing hypertension.  But would an expanded scope of practice that enabled pharmacists to prescribe and manage antihypertensive therapies be cost-effective?
Guest Authors: Stefania Cian, PharmD and Candice Garwood, PharmD, FCCP, BCPS, BCACP 
Special Guest: Dave Dixon, PharmD, BCACP, CLS
Music by Good Talk

Omeprazole ranks among the top 10 most prescribed medications in the United States, and many patients take proton pump inhibitors (PPIs) for years. Widespread PPI use persists despite data about potential serious adverse effects.  Some worry that PPI use increases the risk of dementia.  Are those worries supported by data?
Guest Authors:  Molly M. Corder, PharmD, BCPS, BCACP and Ryan S. Ades, PharmD, BCPS
Music by Good Talk